Medicare Enrolled
Dr. Paul Adams, M.D.
Hematology & Oncology · Flint, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Adams from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Adams?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Adams
Dr. Paul Adams is a hematology & oncology specialist in Flint, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Adams performed 49,587 Medicare services across 1,367 unique beneficiaries.
Between the years covered by Open Payments, Dr. Adams received a total of $4,035 from 57 pharmaceutical and/or device companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Adams is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 11% volume in MI
$4,035 industry payments
Medicare Practice Summary
Medicare Utilization ↗49,587
Medicare services
Top 11% in MI for hematology & oncology
1,367
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,479 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
37,230 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 4,200 | $18 | $30 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
2,700 | $0 | $4 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,078 | $6 | $24 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
900 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
887 | $7 | $21 |
| Anti-nausea injection (Aloxi/palonosetron) | 680 | $1 | $120 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
583 | $84 | $175 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
248 | $10 | $30 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
153 | $21 | $60 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
138 | $92 | $220 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
133 | $11 | $30 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
98 | $60 | $110 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
89 | $95 | $205 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
80 | $43 | $120 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
59 | $51 | $145 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
58 | $21 | $55 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $57 | $125 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
50 | $47 | $115 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
50 | $113 | $242 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
31 | $1 | $5 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
31 | $1 | $5 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
19 | $1 | $12 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
18 | $61 | $180 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $68 | $160 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
75.9% high complexity
20.4% medium
3.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,035
Total received (2018-2024)
Avg $576/year across 7 years
Top 32% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
192
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,466 (85.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$569 (14.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,129
2023
$1,244
2022
$1,162
2021
$305
2020
$12
2019
$108
2018
$74
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$288
AstraZeneca Pharmaceuticals LP
$100
Genentech USA, Inc.
$67
E.R. Squibb & Sons, L.L.C.
$60
Janssen Biotech, Inc.
$56
Genmab U.S., Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$50
Incyte Corporation
$46
Celgene Corporation
$39
PFIZER INC.
$38
Lilly USA, LLC
$32
Dendreon Pharmaceuticals LLC
$32
Octapharma USA, Inc.
$32
GENZYME CORPORATION
$25
BeiGene USA, Inc.
$24
Gilead Sciences, Inc.
$22
Mirati Therapeutics, Inc.
$22
Kyowa Kirin, Inc.
$21
Deciphera Pharmaceuticals Inc.
$21
Rigel Pharmaceuticals, Inc.
$20
SERVIER PHARMACEUTICALS LLC
$19
Ipsen Biopharmaceuticals, Inc
$18
EMD Serono, Inc.
$16
Astellas Pharma US Inc
$15
Merck Sharp & Dohme LLC
$15
Top 3 companies account for 40.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$594
Genentech USA, Inc.
$308
AstraZeneca Pharmaceuticals LP
$226
Janssen Biotech, Inc.
$199
Pharmacyclics LLC, An AbbVie Company
$184
Celgene Corporation
$155
PFIZER INC.
$154
E.R. Squibb & Sons, L.L.C.
$148
GENZYME CORPORATION
$105
EMD Serono, Inc.
$105
ABBVIE INC.
$100
Amgen Inc.
$99
GlaxoSmithKline, LLC.
$90
Kite Pharma, Inc.
$87
Dendreon Pharmaceuticals LLC
$78
Genmab U.S., Inc.
$77
Astellas Pharma US Inc
$73
Ipsen Biopharmaceuticals, Inc
$72
Foundation Medicine, Inc.
$70
Deciphera Pharmaceuticals Inc.
$69
BeiGene USA, Inc.
$65
Gilead Sciences, Inc.
$65
AVEO Pharmaceuticals, Inc.
$57
Seagen Inc.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$50
Lilly USA, LLC
$49
Incyte Corporation
$46
Regeneron Healthcare Solutions, Inc.
$40
Rigel Pharmaceuticals, Inc.
$38
Karyopharm Therapeutics Inc.
$37
G1 Therapeutics, Inc.
$35
Coherus Biosciences Inc.
$33
Octapharma USA, Inc.
$32
JAZZ PHARMACEUTICALS INC.
$25
TOLMAR Pharmaceuticals, Inc.
$23
TerSera Therapeutics LLC
$23
Daiichi Sankyo Inc.
$23
Mirati Therapeutics, Inc.
$22
Eisai Inc.
$22
Kyowa Kirin, Inc.
$21
Myovant Sciences Inc.
$21
Philips Electronics North America Corporation
$20
Verity Pharmaceuticals Inc.
$20
Spectrum Pharmaceuticals Inc.
$19
SERVIER PHARMACEUTICALS LLC
$19
Acrotech Biopharma LLC
$19
Merck Sharp & Dohme Corporation
$18
Pharmacosmos Therapeutics Inc.
$17
Myriad Genetic Laboratories, Inc.
$17
AMAG Pharmaceuticals, Inc.
$17
Novo Nordisk Inc
$16
Acrotech Biopharma Inc.
$15
Emmaus Medical, Inc.
$15
Merck Sharp & Dohme LLC
$15
Smith+Nephew, Inc.
$15
GE HealthCare
$12
Pharmacyclics LLC, an AbbVie Company
$12
Top 3 companies account for 28.0% of all-time payments
Associated products mentioned in payments ›
Abraxane · Alecensa · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRUKINSA · Blincyto · BrillCT BigBore Base · CABLIVI · CALQUENCE · COSELA · Columvi · DARZALEX · ELIGARD · ELIQUIS · ENHERTU · ENJAYMO · ERLEADA · Endari · Enhertu · Epkinly · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · IBRANCE · ICLUSIG · IMBRUVICA · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONOFERRIC · MYRISK · Novoeight · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · PADCEV · PEMAZYRE · PRALUENT ALIROCUMAB INJECTION · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · STRAVIX · TAGRISSO · TECENTRIQ · TECVAYLI · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trelstar · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · Venclexta · XPOVIO · XTANDI · XYNTHA · Xermelo · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
16
Per 100K population
4.0
County median income
$60,673
Nearest hospital
HURLEY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Adams is a mixed practice specialist, with above-average Medicare volume (top 11% in MI), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Adams experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Adams performed 37,230 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Adams receive payments from pharmaceutical companies?
Yes. Dr. Adams received a total of $4,035 from 57 companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Adams's costs compare to other hematology & oncology specialists in Flint?
Dr. Adams's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Adams) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Flint
Browse hematology & oncology specialists in Flint ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology